-
Information-Publications
-
Key Interaction Changes Determine the Activation Process of Human Parathyroid Hormone Type 1 ReceptorDetails -
CBX7 represses the POU2F2 to inhibit the PD-L1 expression and regulate the immune response in bladder cancerDetails -
YTHDC1 is downregulated by the YY1/HDAC2 complex and controls the sensitivity of ccRCC to sunitinib by targeting the ANXA1-MAPK pathwayDetails -
TRIM15 forms a regulatory loop with the AKT/FOXO1 axis and LASP1 to modulate the sensitivity of HCC cells to TKIsDetails -
Pterostilbene interferes with lipopolysaccharide-induced myocardial injury through oxidative stress and inflammasome pathwaysDetails -
Upregulation of CSNK1A1 induced by ITGB5 confers to hepatocellular carcinoma resistance to sorafenib in vivo by disrupting the EPS15/EGFR complexDetails
-
"Heyuan Liji" is a joint venture between Heyuan Biotechnology (stock code: 688238) and Liji Biotechnology, specializing in the "Liji Biotechnology" and "Life-ilab" reagent brands
Back
